Bst Polymerase Variants for Standalone RT-LAMP RNA Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing Bst DNA polymerases (DNAPs) used in loop-mediated isothermal amplification (LAMP) assays have minimal reverse transcriptase (RT) activity, necessitating the use of additional RT enzymes for efficient RNA amplification, which increases cost and complexity.

Innovation Solution

Development of Bst polymerase variants with enhanced RT activity, such as WT-Δexo-Bst496, which includes mutations like P597R, A639T, D775Q, or M792I, allowing for standalone RNA amplification in LAMP assays without additional RT enzymes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If additional RT enzymes are used for RNA amplification in LAMP assays, then amplification sensitivity is improved, but assay complexity and cost increase

Engineering Contradiction:
Improveamplification sensitivityVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines the DNA polymerase activity and reverse transcriptase activity into a single Bst polymerase enzyme. The engineered Bst polymerase contains both the catalytic domain for DNA synthesis and the reverse transcriptase domain for RNA-to-DNA conversion, eliminating the need for separate RT enzyme addition and simplifying the assay protocol while maintaining amplification sensitivity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The Bst polymerase is engineered to perform multiple functions: it acts as both a DNA-dependent DNA polymerase for amplifying DNA templates and as an RNA-dependent DNA polymerase (reverse transcriptase) for converting RNA templates to DNA. This multi-functionality allows a single enzyme to handle both DNA and RNA amplification in LAMP assays

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If additional RT enzymes are used for RNA amplification in LAMP assays, then amplification sensitivity is improved, but reagent cost increases

Engineering Contradiction:
Improveamplification sensitivityVSAvoidreagent cost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent combines the DNA polymerase activity and reverse transcriptase activity into a single Bst polymerase enzyme. The engineered Bst polymerase contains both the catalytic domain for DNA synthesis and the reverse transcriptase domain for RNA-to-DNA conversion, eliminating the need for separate RT enzyme addition and simplifying the assay protocol while maintaining amplification sensitivity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The Bst polymerase is engineered to perform multiple functions: it acts as both a DNA-dependent DNA polymerase for amplifying DNA templates and as an RNA-dependent DNA polymerase (reverse transcriptase) for converting RNA templates to DNA. This multi-functionality allows a single enzyme to handle both DNA and RNA amplification in LAMP assays

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The enhanced RT activity of Bst polymerase variants improves assay sensitivity and reduces costs by eliminating the need for supplemental RT enzymes, thereby improving the effectiveness of RNA and DNA sequence amplification in LAMP assays.

Implementation Method 1

Bst polymerases with enhanced reverse transcriptase (RT) activity for use in amplification assays

Methodology Applied
Scientific EffectReverse transcriptase activity: Enzyme

Implementation Method 2

Bst DNA polymerases (DNAPs) are commonly used for amplification of DNA sequences in a LAMP assay

Methodology Applied
Scientific EffectDNA polymerase activity: Enzyme

Data Source

PatentUS20250382591A1Bst polymerases with reverse transcriptase activity
Publication Date: 2025.12.18 VARIGEN BIOSCIENCES DBA VARIZYMES
  • US20250382591A1 patent drawing
  • US20250382591A1 patent drawing
  • US20250382591A1 patent drawing

AI summary

Provided herein are compositions and methods for use in amplification assays. In particular, provided herein are Bst polymerases with enhanced reverse transcriptase (RT) activity for use in amplification assays such as, for example, loop-mediated isothermal amplification (LAMP) assays.